CHERRY HILL, N.J., Aug. 25 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today that it will issue a shareholder newsletter on September 1, 2009. Additionally, regional shareholder meetings will be held in New York City on September 16th, Chicago on September 17th, and Los Angeles on September 18th. Regional shareholder meeting times and locations will be announced on or before September 7, 2009.
"We are very aware of our shareholders' interest in our business endeavors," stated Martin Schmieg, Chairman and Chief Executive Officer of Nuvilex, Inc. "Like all public companies, the accounting and legal requirements of what we can and must say in our annual and quarterly SEC filings often times paints a less than favorable picture of the positive progress the Company is making in product development, marketing and sales and improving its financial condition."
"Nuvilex is a Company with great promise and a strong future," continued Schmieg. Unlike most development and early revenue stage companies who typically have a single technology or product, Nuvilex has ten unique product opportunities in four diverse markets.
The current business challenge facing Nuvilex is successfully marketing the company's high quality, differentiated and competitively priced products. "We believe these products will become highly sought after, but this will only happen after consumers become aware that our products exist and can be easily obtained," said Schmieg. "This requires building brand awareness and distribution channels."
As a small company, Nuvilex, plans to market the Company's products effectively and efficiently without raising large sums of money (highly dilutive) through the following three-part business strategy:
"Performance is the key to our success. Product performance, market performance, revenue performance, profit performance and management performance will drive Nuvilex' value, your return on investment," stated Schmieg. "Nuvilex has and continues to be successful at building outstanding products. The Company's next challenge is market performance. Market performance will be achieved by putting in place the resources, human and financial, that are needed to build brand awareness and distribution of our products. As consumers become aware of our products, revenue and profit performance will follow. Management is committed and dedicated to implementing and executing business strategies that are achievable and measurable."
The management of Nuvilex believes that the stage is set for Company's future. In collaboration with its major shareholders, Nuvilex has secured non-dilutive financing to ensure the Company has sufficient time to achieve its short-term marketing and sales goals and conclude its current business development activities -- partnership and out-licensing negotiations.
About Nuvilex, Inc.
Nuvilex, Inc. is an emerging healthcare consumer products company. The Company's lead products include: Last Shot Hangover Remedy, a unique sugar-free, calorie-free and caffeine-free liquid formula designed to ease the symptoms of a hangover; Cinnergen, which promotes a healthy glucose metabolism; Cinnechol, designed to help maintain normal cholesterol levels and support normal cardiovascular function; and Infinitink( (R)), a permanent yet more easily removable tattoo ink. The Company's complete portfolio spans aesthetics, dermatology, environmental and nutraceutical products, all of which are designed to directly or indirectly improve human health. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., the developer of Infinitink( (R)). In conjunction with the merger, the Company changed its name to Nuvilex, Inc. from eFoodSafety.com. Please visit www.nuvilex.com for additional information on the Company.
Safe Harbor Statement
Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
Company Contact: Blair Barnes Senior Vice President and Chief Financial Officer Nuvilex, Inc. Ph: 856-433-6088 Email: firstname.lastname@example.org Press Contact: Pat Arcand Arcand & Madison Ph: 617-576-7777 Email: email@example.com
|SOURCE Nuvilex, Inc.|
Copyright©2009 PR Newswire.
All rights reserved